{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:59:09Z","timestamp":1794610749226,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/Fellowship\/0030\/2016"],"award-info":[{"award-number":["NMRC\/Fellowship\/0030\/2016"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CSSSP\/0014\/2017"],"award-info":[{"award-number":["NMRC\/CSSSP\/0014\/2017"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Subjective cognitive decline (SCD) and anxiety symptoms both predict neurocognitive disorders, but the two correlate strongly with each other. It is unclear whether they reflect two independent disease processes in the development of neurocognitive disorders and hence deserve separate attention. This cohort study examined whether SCD and anxiety symptoms demonstrate independent risks of mild cognitive disorder and dementia (MCI\/dementia).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study included 14,066 participants aged \u2265\u200950\u2009years and diagnosed with normal cognition at baseline, recruited from Alzheimer\u2019s Disease Centers across the USA. The participants were evaluated for SCD and anxiety symptoms at baseline and followed up almost annually for incident MCI\/dementia (median follow-up 4.5\u2009years; interquartile range 2.2\u20137.7\u2009years). SCD and anxiety symptoms were included in Cox regression to investigate their independent risks of MCI\/dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SCD and anxiety symptoms demonstrated independent risks of MCI\/dementia, with HR 1.9 (95% CI 1.7\u20132.1) and 1.3 (95% CI 1.2\u20131.5), respectively. Co-occurring SCD and anxiety symptoms demonstrated the highest risk (HR 2.4, 95% CI 1.9\u20132.9)\u2014participants in this group had a 25% probability of developing MCI\/dementia by 3.1\u2009years (95% 2.4\u20133.7), compared to 8.2\u2009years among those without SCD or anxiety (95% CI 7.9\u20138.6). The results remained robust even in the sensitivity analyses that took into account symptom severity and consistency of symptoms in the first 2 annual visits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings suggest that clinicians should not dismiss one over the other when patients present with both SCD and anxiety and that both constructs may potentially be useful to identify high-risk populations for preventive interventions and trials. The findings also point to the need for further research to clarify on the neurobiological distinctions between SCD and anxiety symptoms, which may potentially enrich our understanding on the pathogenesis of neurocognitive disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-020-00673-8","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T03:03:37Z","timestamp":1599793417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1555-7752","authenticated-orcid":false,"given":"Tau Ming","family":"Liew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"issue":"6","key":"673_CR1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2014;10(6):844\u201352.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"673_CR2","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1093\/geront\/gnw091","volume":"56","author":"NL Hill","year":"2016","unstructured":"Hill NL, Mogle J, Wion R, Munoz E, DePasquale N, Yevchak AM, Parisi JM. Subjective cognitive impairment and affective symptoms: a systematic review. Gerontologist. 2016;56(6):e109\u201327.","journal-title":"Gerontologist"},{"issue":"1","key":"673_CR3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13195-019-0527-7","volume":"11","author":"TM Liew","year":"2019","unstructured":"Liew TM. Depression, subjective cognitive decline, and the risk of neurocognitive disorders. Alzheimers Res Ther. 2019;11(1):70.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"673_CR4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ageing\/afn147","volume":"37","author":"AJ Mitchell","year":"2008","unstructured":"Mitchell AJ. Is it time to separate subjective cognitive complaints from the diagnosis of mild cognitive impairment? Age Ageing. 2008;37(5):497\u20139.","journal-title":"Age Ageing"},{"issue":"1","key":"673_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpsychires.2013.10.005","volume":"48","author":"A Singh-Manoux","year":"2014","unstructured":"Singh-Manoux A, Dugravot A, Ankri J, Nabi H, Berr C, Goldberg M, Zins M, Kivimaki M, Elbaz A. Subjective cognitive complaints and mortality: does the type of complaint matter? J Psychiatr Res. 2014;48(1):73\u20138.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"673_CR6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2050-7283-1-19","volume":"1","author":"J Holmen","year":"2013","unstructured":"Holmen J, Langballe E, Midthjell K, Lingaas Holmen T, Fiksaune A, Saltvedt I, Tambs K. Gender differences in subjective memory impairment in a general population: the HUNT study, Norway. BMC Psychol. 2013;1(1):19.","journal-title":"BMC Psychol"},{"issue":"3","key":"673_CR7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jalz.2016.09.012","volume":"13","author":"JL Molinuevo","year":"2017","unstructured":"Molinuevo JL, Rabin LA, Amariglio R, Buckley R, Dubois B, Ellis KA, Ewers M, Hampel H, Kloppel S, Rami L, et al. Implementation of subjective cognitive decline criteria in research studies. Alzheimers Dement. 2017;13(3):296\u2013311.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"673_CR8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"key":"673_CR9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.maturitas.2018.10.014","volume":"119","author":"J Santabarbara","year":"2019","unstructured":"Santabarbara J, Lipnicki DM, Villagrasa B, Lobo E, Lopez-Anton R. Anxiety and risk of dementia: systematic review and meta-analysis of prospective cohort studies. Maturitas. 2019;119:14\u201320.","journal-title":"Maturitas"},{"issue":"10","key":"673_CR10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jagp.2016.05.015","volume":"24","author":"B Gulpers","year":"2016","unstructured":"Gulpers B, Ramakers I, Hamel R, Kohler S, Oude Voshaar R, Verhey F. Anxiety as a predictor for cognitive decline and dementia: a systematic review and meta-analysis. Am J Geriatr Psychiatry. 2016;24(10):823\u201342.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"673_CR11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1192\/bjp.2018.173","volume":"213","author":"E Becker","year":"2018","unstructured":"Becker E, Orellana Rios CL, Lahmann C, Rucker G, Bauer J, Boeker M. Anxiety as a risk factor of Alzheimer\u2019s disease and vascular dementia. Br J Psychiatry. 2018;213(5):654\u201360.","journal-title":"Br J Psychiatry"},{"issue":"10113","key":"673_CR12","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","volume":"390","author":"G Livingston","year":"2017","unstructured":"Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673\u2013734.","journal-title":"Lancet"},{"issue":"9984","key":"673_CR13","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R, Backman L, Hanninen T, Jula A, Laatikainen T, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255\u201363.","journal-title":"Lancet"},{"issue":"4","key":"673_CR14","first-page":"270","volume":"18","author":"DL Beekly","year":"2004","unstructured":"Beekly DL, Ramos EM, van Belle G, Deitrich W, Clark AD, Jacka ME, Kukull WA. The National Alzheimer\u2019s Coordinating Center (NACC) database: an Alzheimer disease database. Alzheimer Dis Assoc Disord. 2004;18(4):270\u20137.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"673_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"issue":"1\u20132","key":"673_CR16","first-page":"165","volume":"5","author":"JI Sheikh","year":"1986","unstructured":"Sheikh JI, Yesavage JA. Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1\u20132):165\u201373.","journal-title":"Clin Gerontol"},{"issue":"7","key":"673_CR17","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archneur.62.7.1160","volume":"62","author":"RC Petersen","year":"2005","unstructured":"Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol. 2005;62(7):1160\u20133 discussion 1167.","journal-title":"Arch Neurol"},{"key":"673_CR18","doi-asserted-by":"crossref","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer\u2019s disease. Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease 1984, 34(7):939\u2013939.","DOI":"10.1212\/WNL.34.7.939"},{"key":"673_CR19","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-IV-TR","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington: American Psychiatric Association; 2000."},{"issue":"3","key":"673_CR20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"2","key":"673_CR21","first-page":"250","volume":"43","author":"GC Rom\u00e1n","year":"1993","unstructured":"Rom\u00e1n GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo J-M, Brun A, Hofman A, et al. Vascular dementia. Diagn Criteria Res Studi. 1993;43(2):250.","journal-title":"Diagn Criteria Res Studi"},{"issue":"1","key":"673_CR22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88\u2013100.","journal-title":"Neurology"},{"issue":"5","key":"673_CR23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mds.10459","volume":"18","author":"I Litvan","year":"2003","unstructured":"Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord. 2003;18(5):467\u201386.","journal-title":"Mov Disord"},{"issue":"12","key":"673_CR24","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863\u201372.","journal-title":"Neurology"},{"issue":"Pt 9","key":"673_CR25","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EGP, Onyike CU, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456\u201377.","journal-title":"Brain"},{"issue":"Pt 1","key":"673_CR26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/brain\/awn291","volume":"132","author":"G Bensimon","year":"2009","unstructured":"Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain. 2009;132(Pt 1):156\u201371.","journal-title":"Brain"},{"issue":"5","key":"673_CR27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80(5):496\u2013503.","journal-title":"Neurology"},{"issue":"5","key":"673_CR28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293\u20139.","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"6","key":"673_CR29","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546\u201354.","journal-title":"Neurology"},{"issue":"1","key":"673_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47(1):1\u20139.","journal-title":"Neurology"},{"key":"673_CR31","volume-title":"Stata survival analysis reference manual release 14","author":"StataCorp","year":"2015","unstructured":"StataCorp. Stata survival analysis reference manual release 14. Texas: Stata Press; 2015."},{"issue":"8","key":"673_CR32","first-page":"1054.e1051","volume":"20","author":"TM Liew","year":"2019","unstructured":"Liew TM. Symptom clusters of neuropsychiatric symptoms in mild cognitive impairment and their comparative risks of dementia: a cohort study of 8530 older persons. J Am Med Dir Assoc. 2019;20(8):1054.e1051\u20139.","journal-title":"J Am Med Dir Assoc"},{"issue":"3","key":"673_CR33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/0962280210395740","volume":"22","author":"SR Seaman","year":"2013","unstructured":"Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res. 2013;22(3):278\u201395.","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"673_CR34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13195-020-00604-7","volume":"12","author":"TM Liew","year":"2020","unstructured":"Liew TM. Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer\u2019s and non-Alzheimer\u2019s dementia. Alzheimers Res Ther. 2020;12(1):35.","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"673_CR35","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3233\/JAD-160407","volume":"54","author":"S Wolfsgruber","year":"2016","unstructured":"Wolfsgruber S, Kleineidam L, Wagner M, M\u00f6sch E, Bickel H, L\u03cbhmann D, Ernst A, Wiese B, Steinmann S, K\u00f6nig HH, et al. Differential risk of incident Alzheimer\u2019s disease dementia in stable versus unstable patterns of subjective cognitive decline. J Alzheimers Dis. 2016;54(3):1135\u201346.","journal-title":"J Alzheimers Dis"},{"issue":"7, Supplement","key":"673_CR36","doi-asserted-by":"crossref","first-page":"P639","DOI":"10.1016\/j.jalz.2018.06.2685","volume":"14","author":"J Cano","year":"2018","unstructured":"Cano J, Chan V, Kan CN, Chen C, Hilal S, Venketasubramanian N, Xu X. Mild behavioral impairment: prevalence in clinical setting and cognitive correlates. Alzheimer\u2019s Dement. 2018;14(7, Supplement):P639\u201340.","journal-title":"Alzheimer\u2019s Dement"},{"key":"673_CR37","doi-asserted-by":"publisher","unstructured":"Ismail Z, McGirr A, Gill S, Hu S, Forkert ND, Smith EE. Mild behavioral impairment and subjective cognitive decline predict mild cognitive impairment. medRxiv 2020;05(24):20112284. https:\/\/doi.org\/10.1101\/2020.05.24.20112284. http:\/\/medrxiv.org\/content\/early\/2020\/05\/25\/2020.05.24.20112284.abstract.","DOI":"10.1101\/2020.05.24.20112284"},{"issue":"4","key":"673_CR38","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1212\/WNL.0000000000005863","volume":"91","author":"AC van Harten","year":"2018","unstructured":"van Harten AC, Mielke MM, Swenson-Dravis DM, Hagen CE, Edwards KK, Roberts RO, Geda YE, Knopman DS, Petersen RC. Subjective cognitive decline and risk of MCI: the Mayo Clinic Study of Aging. Neurology. 2018;91(4):e300\u201312.","journal-title":"Neurology"},{"issue":"1","key":"673_CR39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12877-016-0353-8","volume":"16","author":"S Roehr","year":"2016","unstructured":"Roehr S, Villringer A, Angermeyer MC, Luck T, Riedel-Heller SG. Outcomes of stable and unstable patterns of subjective cognitive decline - results from the Leipzig Longitudinal Study of the Aged (LEILA75+). BMC Geriatr. 2016;16(1):180.","journal-title":"BMC Geriatr"},{"issue":"8","key":"673_CR40","first-page":"1054.e1011","volume":"20","author":"TM Liew","year":"2019","unstructured":"Liew TM. Developing a brief neuropsychological battery for early diagnosis of cognitive impairment. J Am Med Dir Assoc. 2019;20(8):1054.e1011\u201320.","journal-title":"J Am Med Dir Assoc"},{"key":"673_CR41","doi-asserted-by":"publisher","unstructured":"Liew TM. Active case finding of dementia in ambulatory care settings: a comparison of three strategies [published online ahead of print, 2020 May 22].. Eur J Neurol. 2020;10.1111\/ene.14353. https:\/\/doi.org\/10.1111\/ene.14353.","DOI":"10.1111\/ene.14353"},{"key":"673_CR42","doi-asserted-by":"crossref","unstructured":"Liew TM. A 4-Item case-finding tool to detect dementia in older persons. J Am Med Dir Assoc. 2019;20(12):1529\u20131534.e6.","DOI":"10.1016\/j.jamda.2019.06.015"},{"key":"673_CR43","doi-asserted-by":"crossref","unstructured":"Liew TM. The optimal short version of montreal cognitive assessment in diagnosing mild cognitive impairment and dementia. J Am Med Dir Assoc. 2019;20(8):1055.e1\u20131055.e8.","DOI":"10.1016\/j.jamda.2019.02.004"},{"key":"673_CR44","doi-asserted-by":"crossref","first-page":"101612","DOI":"10.1016\/j.nicl.2018.101612","volume":"21","author":"L Scheef","year":"2019","unstructured":"Scheef L, Grothe MJ, Koppara A, Daamen M, Boecker H, Biersack H, Schild HH, Wagner M, Teipel S, Jessen F. Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD). Neuroimage Clin. 2019;21:101612.","journal-title":"Neuroimage Clin"},{"issue":"1","key":"673_CR45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S0959259812000172","volume":"23","author":"RE Mark","year":"2013","unstructured":"Mark RE, Sitskoorn MM. Are subjective cognitive complaints relevant in preclinical Alzheimer\u2019s disease? A review and guidelines for healthcare professionals. Rev Clin Gerontol. 2013;23(1):61\u201374.","journal-title":"Rev Clin Gerontol"},{"issue":"10","key":"673_CR46","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2174\/1567205013666160502123607","volume":"13","author":"D Van Dam","year":"2016","unstructured":"Van Dam D, Vermeiren Y, Dekker AD, Naud\u00e9 PJW, Deyn PPD. Neuropsychiatric disturbances in Alzheimer\u2019s disease: what have we learned from neuropathological studies? Curr Alzheimer Res. 2016;13(10):1145\u201364.","journal-title":"Curr Alzheimer Res"},{"issue":"9","key":"673_CR47","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/ene.13958","volume":"26","author":"TM Liew","year":"2019","unstructured":"Liew TM, Yap P, Ng TP, Mahendran R, Kua EH, Feng L. Symptom clusters of subjective cognitive decline amongst cognitively normal older persons and their utilities in predicting objective cognitive performance: structural equation modelling. Eur J Neurol. 2019;26(9):1153\u201360.","journal-title":"Eur J Neurol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00673-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-020-00673-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00673-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T20:14:12Z","timestamp":1631304852000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00673-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00673-8","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"19 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All contributing Alzheimer\u2019s Disease Centers obtained informed consent from their participants, as well as received approval by their local institutional review boards. Research using the NACC database was also approved by the University of Washington Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}